Current Treatment Options in Oncology

SJR Rank #2,095H-index: 77SJR: 1.626Best quartile: Q1APC: US$4,890
Journal website: aims, scope and author guidelines
Publisher

Springer

Country

United States

Type

journal

SJR by Edition

2022202500.450.91.351.8

Subject Categories

  • OncologyQ1
  • Pharmacology (medical)Q1

Areas: Medicine

Most published research topics

Lymphoma Diagnosis and TreatmentSarcoma Diagnosis and TreatmentLung Cancer Research StudiesLung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersGlioma Diagnosis and TreatmentCAR-T cell therapy researchNeuroendocrine Tumor Research AdvancesChronic Lymphocytic Leukemia ResearchColorectal Cancer Treatments and Studies

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs085170255340

Documents per Year

202220250306090120

Detailed Information

ISSN

1534-6277, 1527-2729

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

5.87

References per Document

90.37

Coverage

2000-2026

Scope

This journal aims to review the most important, recently published treatment option advances in the field of oncology. By providing clear, insightful, balanced contributions by international experts, the journal intends to facilitate worldwide approaches to cancer treatment. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as endocrine tumors, lymphomas, neuro-oncology, and cancers of the breast, head and neck, lung, skin, gastrointestinal tract, and genitourinary region. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. We also provide commentaries from well-known oncologists, and an international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research.

Metrics from SCImago Journal Rank 2025. View on SCImago